NasdaqGS - Delayed Quote • USD
Henry Schein, Inc. (HSIC)
At close: April 18 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 14 | 13 |
| Avg. Estimate | 1.01 | 1.27 | 5.07 | 5.63 |
| Low Estimate | 0.82 | 1.18 | 5.03 | 5.52 |
| High Estimate | 1.11 | 1.34 | 5.1 | 5.92 |
| Year Ago EPS | 1.21 | 1.31 | 4.5 | 5.07 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 13 | 13 |
| Avg. Estimate | 3.21B | 3.3B | 13.42B | 14.08B |
| Low Estimate | 3.1B | 3.25B | 13.32B | 13.83B |
| High Estimate | 3.28B | 3.38B | 13.63B | 14.39B |
| Year Ago Sales | -- | 3.1B | 12.34B | 13.42B |
| Sales Growth (year/est) | -- | 6.50% | 8.80% | 4.90% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 1.23 | 1.28 | 1.32 | 0.69 |
| EPS Actual | 1.21 | 1.31 | 1.32 | 0.66 |
| Difference | -0.02 | 0.03 | 0 | -0.03 |
| Surprise % | -1.60% | 2.30% | 0.00% | -4.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.01 | 1.27 | 5.07 | 5.63 |
| 7 Days Ago | 1.01 | 1.26 | 5.08 | 5.66 |
| 30 Days Ago | 1.01 | 1.26 | 5.08 | 5.66 |
| 60 Days Ago | 1.1 | 1.29 | 5.12 | 5.62 |
| 90 Days Ago | 1.1 | 1.3 | 5.11 | 5.66 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 1 | 1 |
| Up Last 30 Days | 1 | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 2 | 2 |
Growth Estimates
| CURRENCY IN USD | HSIC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -16.50% | -- | -- | 0.80% |
| Next Qtr. | -3.10% | -- | -- | 9.60% |
| Current Year | 12.70% | -- | -- | 4.50% |
| Next Year | 11.00% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 7.25% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 4.35% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | JP Morgan: Overweight to Overweight | 3/6/2024 |
| Maintains | Jefferies: Hold to Hold | 3/6/2024 |
| Maintains | Evercore ISI Group: In-Line to In-Line | 2/28/2024 |
| Maintains | Barrington Research: Outperform to Outperform | 2/28/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 2/26/2024 |
| Initiated | Leerink Partners: Market Perform | 2/26/2024 |
Related Tickers
PDCO Patterson Companies, Inc.
25.47
0.00%
OMI Owens & Minor, Inc.
24.06
+0.38%
COR Cencora, Inc.
237.30
-0.55%
CAH Cardinal Health, Inc.
106.00
-0.49%
ILM1.F Medios AG
14.02
-1.41%
ARJO-B.ST Arjo AB (publ)
46.62
+0.52%
GALE.SW Galenica AG
69.80
-0.07%
AHG Akso Health Group
0.9898
+16.45%
MCK McKesson Corporation
518.81
-1.35%
YI 111, Inc.
1.0000
0.00%